Utility of antenatal HIV surveillance data to evaluate prevention of mother-to-child HIV transmission programs in resource-limited settings

被引:20
作者
Bolu, Omotayo
Anand, Abhijeet
Swartzendruber, Andrea
Hladik, Wolfgang
Lawrence, H.
Sheikh, Abdullahi Ahmed
Woldu, Aseged
Ismail, Shabbir
Mahomva, Agnes
Greby, Stacie
Sabin, Keith
机构
[1] Natl Ctr HIV Hepatitis STD & TB Prevent, Global AIDS Program, Prevent Mother To Child Transmiss Team, Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Global AIDS Program, Entebbe, Uganda
[3] Ctr Dis Control & Prevent, Global AIDS Program, Nairobi, Kenya
[4] Natl AIDS STD Control Program, Nairobi, Kenya
[5] Fed Minist Hlth, Natl HIV AIDS Prevent & Control Off, Addis Ababa, Ethiopia
[6] Ctr Dis Control & Prevent, Global AIDS Program, Addis Ababa, Ethiopia
[7] Elizabeth Glazer Pediat AIDS Fdn, Harare, Zimbabwe
[8] Ctr Dis Control & Prevent, Global AIDS Program, Harare, Zimbabwe
关键词
antenatal clinics; Ethiopia; human immunodeficiency virus; Kenya; prevention of mother to child human immunodeficiency virus transmission surveillance data; Zimbabwe;
D O I
10.1016/j.ajog.2007.03.082
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Prevention of mother-to-child human immunodeficiency virus (HIV) transmission (PMTCT) programs are expanding in resource-limited countries and are increasingly implemented in antenatal clinics (ANC) in which HIV sentinel surveillance is conducted. ANC sentinel surveillance data can be used to evaluate the first visit of a pregnant woman to PMTCT programs. We analyzed data from Kenya and Ethiopia, where information on PMTCT test acceptance was collected on the 2005 ANC sentinel surveillance forms. For Zimbabwe, we compared the 2005 ANC sentinel surveillance data to the PMTCT program data. ANC surveillance data allowed us to calculate the number of HIV-positive women not participating in the PMTCT program. The percentage of HIV-positive women missed by the PMTCT program was 17% in Kenya, 57% Ethiopia, and 59% Zimbabwe. The HIV prevalence among women participating in PMTCT differed from women who did not. ANC sentinel surveillance can be used to evaluate and improve the first encounter in PMTCT programs. Countries should collect PMTCT-related program data through ANC surveillance to strengthen the PMTCT program.
引用
收藏
页码:S17 / S25
页数:9
相关论文
共 20 条
[1]  
[Anonymous], 2003, RIGHT KNOW NEW APPR
[2]   Using HIV voluntary counseling and testing data for monitoring the Uganda HIV epidemic, 1992-2000 [J].
Baryarama, F ;
Bunnell, RE ;
Ransom, RL ;
Ekwaru, JP ;
Kalule, J ;
Tumuhairwe, EB ;
Mermin, JH .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (01) :1180-1186
[3]  
BUYSE D, 2002, 14 INT C AIDS BARC I
[4]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P1083
[5]   Prevention of mother-to-child HIV transmission in resource-poor countries - Translating research into policy and practice [J].
De Cock, KM ;
Fowler, MG ;
Mercier, E ;
de Vincenzi, I ;
Saba, J ;
Hoff, E ;
Alnwick, DJ ;
Rogers, M ;
Shaffer, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1175-1182
[6]   Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century [J].
De Cock, KM ;
Mbori-Ngacha, D ;
Marum, E .
LANCET, 2002, 360 (9326) :67-72
[7]   Using prevalence data from the programme for the prevention of mother-to-child-transmission for HIV-1 surveillance in North Uganda [J].
Fabiani, M ;
Nattabi, B ;
Ayella, EO ;
Ogwang, M ;
Declich, S .
AIDS, 2005, 19 (08) :823-827
[8]   Evidence of success in HIV prevention in Africa [J].
Grulich, AE ;
Kaldor, JM .
LANCET, 2002, 360 (9326) :3-4
[9]   Prevention of mother-to-child transmission and voluntary counseling and testing programme data: what is their utility for HIV surveillance? [J].
Hladik, W ;
Masupu, K ;
Roels, T ;
Plipat, T ;
Kaharuza, F ;
Bunnell, R ;
Seguy, N ;
Marum, LH .
AIDS, 2005, 19 :S19-S24
[10]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial [J].
Jackson, JB ;
Musoke, P ;
Fleming, T ;
Guay, LA ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Owor, M ;
Ducar, C ;
Deseyve, M ;
Mwatha, A ;
Emel, L ;
Duefield, C ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Gigliotti, M ;
Bray, D ;
Mmiro, F .
LANCET, 2003, 362 (9387) :859-868